Enliven Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants (NCT06787144) | Enliven Therapeutics | 2025-01-23 |
| ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer (NCT06328738) | Enliven Therapeutics | 2024-05-30 |
| ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer (NCT05650879) | Enliven Therapeutics | 2023-03-20 |
| A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia (NCT05304377) | Enliven Therapeutics | 2022-05-22 |
Track Enliven Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.